BioCentury
ARTICLE | Politics & Policy

FDA panel recommends lifting SCID holds

October 10, 2002 7:00 AM UTC

FDA's Biological Response Modifiers Committee on Thursday recommended lifting last week's holds on three U.S. trials of gene therapies for severe combined immune deficiency disease (SCID). The U.S. tr...